74 research outputs found
Ising Universality in Three Dimensions: A Monte Carlo Study
We investigate three Ising models on the simple cubic lattice by means of
Monte Carlo methods and finite-size scaling. These models are the spin-1/2
Ising model with nearest-neighbor interactions, a spin-1/2 model with
nearest-neighbor and third-neighbor interactions, and a spin-1 model with
nearest-neighbor interactions. The results are in accurate agreement with the
hypothesis of universality. Analysis of the finite-size scaling behavior
reveals corrections beyond those caused by the leading irrelevant scaling
field. We find that the correction-to-scaling amplitudes are strongly dependent
on the introduction of further-neighbor interactions or a third spin state. In
a spin-1 Ising model, these corrections appear to be very small. This is very
helpful for the determination of the universal constants of the Ising model.
The renormalization exponents of the Ising model are determined as y_t = 1.587
(2), y_h = 2.4815 (15) and y_i = -0.82 (6). The universal ratio Q =
^2/ is equal to 0.6233 (4) for periodic systems with cubic symmetry.
The critical point of the nearest-neighbor spin-1/2 model is K_c=0.2216546
(10).Comment: 25 pages, uuencoded compressed PostScript file (to appear in Journal
of Physics A
Improved high-temperature expansion and critical equation of state of three-dimensional Ising-like systems
High-temperature series are computed for a generalized Ising model with
arbitrary potential. Two specific ``improved'' potentials (suppressing leading
scaling corrections) are selected by Monte Carlo computation. Critical
exponents are extracted from high-temperature series specialized to improved
potentials, achieving high accuracy; our best estimates are:
, , , ,
. By the same technique, the coefficients of the small-field
expansion for the effective potential (Helmholtz free energy) are computed.
These results are applied to the construction of parametric representations of
the critical equation of state. A systematic approximation scheme, based on a
global stationarity condition, is introduced (the lowest-order approximation
reproduces the linear parametric model). This scheme is used for an accurate
determination of universal ratios of amplitudes. A comparison with other
theoretical and experimental determinations of universal quantities is
presented.Comment: 65 pages, 1 figure, revtex. New Monte Carlo data by Hasenbusch
enabled us to improve the determination of the critical exponents and of the
equation of state. The discussion of several topics was improved and the
bibliography was update
Analysis of multifunctional oxycarbide and oxynitride thin films by modulated IR radiometry
Association of genetic variation with systolic and diastolic blood pressure among African Americans: the Candidate Gene Association Resource study
The prevalence of hypertension in African Americans (AAs) is higher than in other US groups; yet, few have performed genome-wide association studies (GWASs) in AA. Among people of European descent, GWASs have identified genetic variants at 13 loci that are associated with blood pressure. It is unknown if these variants confer susceptibility in people of African ancestry. Here, we examined genome-wide and candidate gene associations with systolic blood pressure (SBP) and diastolic blood pressure (DBP) using the Candidate Gene Association Resource (CARe) consortium consisting of 8591 AAs. Genotypes included genome-wide single-nucleotide polymorphism (SNP) data utilizing the Affymetrix 6.0 array with imputation to 2.5 million HapMap SNPs and candidate gene SNP data utilizing a 50K cardiovascular gene-centric array (ITMAT-Broad-CARe [IBC] array). For Affymetrix data, the strongest signal for DBP was rs10474346 (P= 3.6 × 10−8) located near GPR98 and ARRDC3. For SBP, the strongest signal was rs2258119 in C21orf91 (P= 4.7 × 10−8). The top IBC association for SBP was rs2012318 (P= 6.4 × 10−6) near SLC25A42 and for DBP was rs2523586 (P= 1.3 × 10−6) near HLA-B. None of the top variants replicated in additional AA (n = 11 882) or European-American (n = 69 899) cohorts. We replicated previously reported European-American blood pressure SNPs in our AA samples (SH2B3, P= 0.009; TBX3-TBX5, P= 0.03; and CSK-ULK3, P= 0.0004). These genetic loci represent the best evidence of genetic influences on SBP and DBP in AAs to date. More broadly, this work supports that notion that blood pressure among AAs is a trait with genetic underpinnings but also with significant complexit
Current and prospective pharmacological targets in relation to antimigraine action
Migraine is a recurrent incapacitating neurovascular disorder characterized by unilateral and throbbing headaches associated with photophobia, phonophobia, nausea, and vomiting. Current specific drugs used in the acute treatment of migraine interact with vascular receptors, a fact that has raised concerns about their cardiovascular safety. In the past, α-adrenoceptor agonists (ergotamine, dihydroergotamine, isometheptene) were used. The last two decades have witnessed the advent of 5-HT1B/1D receptor agonists (sumatriptan and second-generation triptans), which have a well-established efficacy in the acute treatment of migraine. Moreover, current prophylactic treatments of migraine include 5-HT2 receptor antagonists, Ca2+ channel blockers, and β-adrenoceptor antagonists. Despite the progress in migraine research and in view of its complex etiology, this disease still remains underdiagnosed, and available therapies are underused. In this review, we have discussed pharmacological targets in migraine, with special emphasis on compounds acting on 5-HT (5-HT1-7), adrenergic (α1, α2, and β), calcitonin gene-related peptide (CGRP 1 and CGRP2), adenosine (A1, A2, and A3), glutamate (NMDA, AMPA, kainate, and metabotropic), dopamine, endothelin, and female hormone (estrogen and progesterone) receptors. In addition, we have considered some other targets, including gamma-aminobutyric acid, angiotensin, bradykinin, histamine, and ionotropic receptors, in relation to antimigraine therapy. Finally, the cardiovascular safety of current and prospective antimigraine therapies is touched upon
Association of genetic variation with systolic and diastolic blood pressure among African Americans: the Candidate Gene Association Resource study.
The prevalence of hypertension in African Americans (AAs) is higher than in other US groups; yet, few have performed genome-wide association studies (GWASs) in AA. Among people of European descent, GWASs have identified genetic variants at 13 loci that are associated with blood pressure. It is unknown if these variants confer susceptibility in people of African ancestry. Here, we examined genome-wide and candidate gene associations with systolic blood pressure (SBP) and diastolic blood pressure (DBP) using the Candidate Gene Association Resource (CARe) consortium consisting of 8591 AAs. Genotypes included genome-wide single-nucleotide polymorphism (SNP) data utilizing the Affymetrix 6.0 array with imputation to 2.5 million HapMap SNPs and candidate gene SNP data utilizing a 50K cardiovascular gene-centric array (ITMAT-Broad-CARe [IBC] array). For Affymetrix data, the strongest signal for DBP was rs10474346 (P= 3.6 × 10(-8)) located near GPR98 and ARRDC3. For SBP, the strongest signal was rs2258119 in C21orf91 (P= 4.7 × 10(-8)). The top IBC association for SBP was rs2012318 (P= 6.4 × 10(-6)) near SLC25A42 and for DBP was rs2523586 (P= 1.3 × 10(-6)) near HLA-B. None of the top variants replicated in additional AA (n = 11 882) or European-American (n = 69 899) cohorts. We replicated previously reported European-American blood pressure SNPs in our AA samples (SH2B3, P= 0.009; TBX3-TBX5, P= 0.03; and CSK-ULK3, P= 0.0004). These genetic loci represent the best evidence of genetic influences on SBP and DBP in AAs to date. More broadly, this work supports that notion that blood pressure among AAs is a trait with genetic underpinnings but also with significant complexity
206 Multiple cytoplasmic steroid hormone receptors in normal and neoplastic vulval tissue
- …